| Dr Thomas Heath Waltz, DO | |
|
2000 Eoff St, Wheeling, WV 26003-3823 | |
| (304) 234-8827 | |
| (304) 234-8426 |
| Full Name | Dr Thomas Heath Waltz |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 2000 Eoff St, Wheeling, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255580585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 58.002059 (Ohio) | Secondary |
| 207R00000X | Internal Medicine | 2269 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reynolds Memorial Hospital | Glen dale, WV | Hospital |
| Barnesville Hospital Association, Inc | Barnesville, OH | Hospital |
| Wetzel County Hospital | New martinsville, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reynolds Memorial Hospital, Inc | 9830184530 | 122 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of West Virginia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649575101 PECOS PAC ID: 2860674488 Enrollment ID: O20110303000157 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
| Entity Name | Wheeling Health Right, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801922596 PECOS PAC ID: 8921367715 Enrollment ID: O20180124002937 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of West Virginia-wheeling, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568940187 PECOS PAC ID: 8729339023 Enrollment ID: O20180926001172 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Heath Waltz, DO 2000 Eoff St, Wheeling, WV 26003-3823 Ph: (304) 234-8827 | Dr Thomas Heath Waltz, DO 2000 Eoff St, Wheeling, WV 26003-3823 Ph: (304) 234-8827 |
News Archive
Document Storage Systems, Inc. (DSS) today announced that Spectron Corp. of Tulsa, OK has become its first distribution partner. Spectron will redistribute vxVistA, DSS' free and open source version of the VistA system and resell DSS' proprietary add-on products.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.
Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.
› Verified 9 days ago
Andrew Kenneth Etzel, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 Chapline St, Wheeling, WV 26003 Phone: 304-234-8885 | |
Rawan F. Kassar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 40 Medical Park Ste 404, Wheeling, WV 26003 Phone: 304-243-2984 Fax: 304-243-6306 | |
Julie Suzanne Bunner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 58 16th St, Wheeling, WV 26003 Phone: 304-243-6410 Fax: 304-243-6411 | |
Marnie J Marker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 58 16th St, Suite 500, Wheeling, WV 26003 Phone: 304-234-1751 Fax: 304-234-1752 | |
Dr. Deepak Hooda, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Medical Park, Suite 104, Wheeling, WV 26003 Phone: 304-242-4800 Fax: 304-242-3580 | |
Dr. Edward Kin Chiu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1307 Mt Dechantal Rd, Wheeling, WV 26003 Phone: 304-242-3043 Fax: 304-242-1422 | |
Charles Clark Milton, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Wheeling Hospital Inc, 1 Medical Park, Wheeling, WV 26003 Phone: 304-243-3124 |